Potter Myrtle S insider trades
Potter Myrtle S has filed 51 Form 4s with the SEC that we hold, for Guardant Health, Inc. (GH) (Director), MYOV (Director) and Ginkgo Bioworks Holdings, Inc. (DNA) (Director). Across all of them we count 0 purchases worth $0 and 7 sales worth $341.9K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($205.8K). The largest single trade was a sale of 1,556 shares of Guardant Health, Inc. worth $204.1K, dated 2026-06-22. The first filing on our record is dated 2021-11-09 and the latest 2026-06-23.
Guardant Health, Inc. (GH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-06-16 | S, sale reported on Form 4 | 2,626 | $130.5K | 2025-06-16 |
| 2025-06-18 | S, sale reported on Form 4 | 26 | $1.3K | 2025-06-20 |
| 2025-07-17 | S, sale reported on Form 4 | 26 | $1.3K | 2025-07-18 |
| 2025-08-19 | S, sale reported on Form 4 | 26 | $1.5K | 2025-08-20 |
| 2025-09-17 | S, sale reported on Form 4 | 26 | $1.4K | 2025-09-17 |
| 2025-10-17 | S, sale reported on Form 4 | 26 | $1.7K | 2025-10-20 |
| 2026-06-22 | S, sale reported on Form 4 | 1,556 | $204.1K | 2026-06-23 |
MYOV
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Ginkgo Bioworks Holdings, Inc. (DNA)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1214130) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms